Neurocrine Corp - Margin operasi NBIX

Logo korporat perusahaan Neurocrine Biosciences (NBIX)

Should growth be expected for Neurocrine Biosciences (NBIX), given that the current success of Ingrezza is already priced in by the market? The answer lies in the operating margin level, where 24.60 captures a new benchmark, confirming the efficiency of this biopharmaceutical innovator in the field of neuroscience. The company's potential is based on large-scale R&D investments, while future share value relies on the success of new molecules for the treatment of depression and schizophrenia.

NBIX: Rentabilitas kegiatan operasi Neurocrine Biosciences, Inc. 04.07.2022 - 20.11.2026

NBIX (Neurocrine Biosciences): rincian analitis lan laporan miturut indikator

Analisis komprehensif perusahaan:Neurocrine Corp, NBIX
Barang utama Neurocrine Corp

Professional capital evaluates the profile of Neurocrine Biosciences (NBIX) through the lens of blockbuster commercialization efficiency and the precision of R&D investments. Analyzing operating profit margins on GURU.Markets, the investor observes the share of core operating profit in revenue, which reflects management's ability to scale a niche business and confirms the asset's fundamental reliability due to high-quality operational expense management.

Analisis pesaing

Margin dodolan operasi BIIB|Regencell Corp (RGC) - Rentabilitas kegiatan operasi|Margin operasi AXSM|Margin dodolan operasi ACADIA Pharmaceuticals ACAD|Margin operasi XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Margin bathi operasi|SUPN - Rentabilitas operasi|Catalyst Pharmaceuticals Inc (CPRX) - Margin dodolan operasi|DNLI (Denali Corp) - Margin dodolan operasi|Rentabilitas dodolan operasi harmonybiosciences.com (HRMY)|Margin dodolan operasi BHVN|Margin operasi Amylyx|Margin operasi TRVI|PRAX (Praxis Corp) - Tingkat bathi operasi|Margin operasi AVXL (anavex.com)|CBLL: Rentabilitas dodolan miturut bathi operasi|PRTA - Rentabilitas operasi|ALEC - Margin operasi|Annexon Inc. (ANNX) - Rentabilitas operasi|Margin dodolan operasi Omeros Corp|Margin dodolan operasi NGNE|ACIU: Tingkat bathi operasi|Margin dodolan operasi VYGR (Voyager Corp)|Margin dodolan operasi Neumora NMRA|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi